Jump to... 

Contact us...

  • Email LSO@vanderbilt.edu if you are interested in an opportunity not listed below or have questions regarding the LSO submission process.

covid

Special Research Focus: COVID-19 Funding Opportunities

Curated collections of funding opportunities

Edge for Scholars offers curated list of COVID-19 funding opportunities

Updated regularly. Check the site often for updates about research funding opportunities, including to special calls & announcements, in response to the coronavirus pandemic. 

Vanderbilt University sites showcase public and private COVID-19 funding

Lists of application opportunities related to COVID-19 have been shared by Office of the Vice Provost for Research (Public funders) and the Office of Corporate and Foundation Relations (Private funders). Updated regularly. 

GrantForward funding database provides list of COVID-19 funding opportunities


Highlighted opportunities

NIH mobilizes $1.5B national innovation initiative for COVID-19 diagnostics

Applications accepted and funded on a rolling basis

The newly-launched NIH Rapid Acceleration of Diagnostics (RADx) initiative aims to speed innovation, development and commercialization of COVID-19 testing technologies. NIH is urging all scientists and inventors with a rapid testing technology to compete in a national COVID-19 testing challenge for a share of up to $500 million over all phases of development. The technologies will be put through a highly competitive, rapid three-phase selection process to identify the best candidates for at-home, point-of-care, and improved laboratory tests that can directly detect SARS-CoV-2, the virus that causes COVID-19. Finalists will be matched with technical, business and manufacturing experts, or immediately advanced to the appropriate step in the commercialization process. The program will support the full range of product development including commercialization and product distribution. A rapid review process will allow quick throughput of projects in order to roll out new products as early as summer 2020.

Apply at https://www.poctrn.org/radx

More about RADx here.

NIAID releases R01 and R21 emergency awards for rapid investigation of SARS-CoV-2 and COVID-19

Applications will be accepted on a rolling basis

The program provides expedited funding for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19).This program is designed to provide expedited funding for research projects focusing on obtaining time-sensitive data in light of this public health emergency (e.g., the research questions cannot be efficiently addressed in another context and the nature of the event and/or impacted populations are well suited for the proposed study). Application budgets are not limited but need to reflect the actual needs of the proposed project.

PAR-20-177 for R21 funding (clinical trial not allowed)

PAR-20-178 for R01 funding (clinical trial not allowed)

COVID-19-Related Enhancements to Existing PCORI Research Projects

Applications accepted on a rolling basis

PCORI seeks investigator-initiated proposals to address the COVID-19 public health crisis through enhancements of currently funded PCORI research awards. Only PCORI-funded principal investigators with active research project funding contracts are eligible to submit a proposal in response to this announcement. Awards will be up to $500,000 (direct + indirect costs) and may not increase project timeline by more than 12 months.

NIH Notice of Special Interest: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) - Multiple Award Types

Applications due in June 2020 and later; See specific RFA for deadline

National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel coronavirus (SARS-CoV-2) and the disease it causes, COVID-19. NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial.

The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair. Examples include the following:

NCATS is soliciting applications to PAR-17-465, PAR-18-462, and PAR-18-332:

Activity Codes

FOA Title

Applicable Dates

UG3/UH3

PAR-17-465: Bench Testing Therapeutic/Indication Paring Strategies (UG3/UH3)

Applicable Receipt Date:

  • June 26, 2020

U34

PA-18-462:Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trial Not Allowed)

Applicable Receipt Date:

  • October 16, 2020

U01

PAR-18-332: Clinic Testing Therapeutic/Indications Pairing Strategies (U01 Clinical Trial Required)

Applicable Receipt Dates:

  • October 5, 2020

 


Research Awards Banner.png

Active Internal Calls for Limited Submission Nominations 

Internal review process required to choose institutional nominees


Limited Submission Eligibility Guidelines

The following tags serve as a guide for submission instructions.

 Vanderbilt (VU + VUMC):  

  • VU and VUMC submit collaboratively to this LSO. ALL investigators should follow the guidelines posted on this site.

 VUMC :

  • VU and VUMC submit separately to this LSO. VUMC investigators should follow the guidelines posted on this site. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

FEATURED OPPORTUNITY

  • High-profile or prestigious awards of particular interest to Vanderbilt investigators

2021 Searle Scholars Program

Applications due July 9

FEATURED OPPORTUNITY

VUMC: These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Overview:

VUMC may nominate two candidates for the 2021 Searle Scholars Program, which supports the independent research of outstanding individuals who have recently begun their first appointments as tenure-track assistant professors.  The Searle Scholars Program Scientific Advisory Board is primarily interested in the potential of applicants to make innovative and high-impact contributions to biomedical research over an extended period of time. Each year, 15 new individuals are named Searle Scholars and awarded $300,000 over three years. Indirect costs are not permitted.

Eligibility:

  • Applicants are expected to be pursuing independent research careers in biochemistry, cell biology, genetics, immunology, neuroscience, pharmacology, and related areas in chemistry, medicine, and the biological sciences.
  • Applicants should have begun their appointment as an independent investigator at the assistant professor level on or after July 1, 2019. The appointment must be their first tenure-track position.
  • The Program does not support purely clinical research but has supported research programs that include both clinical and basic components.
  • Applicants who were nominated for awards in the previous competition year but were not awarded may still meet the eligibility criteria for the current competition. *Contact LSO@vanderbilt.edu if this applies.

Potential applicants who are unsure if their research is appropriate for the Program are encouraged to examine the research interests of present and former Searle Scholars.

Internal Application Process:

Eligible faculty interested in being one of VUMC’s nominees must submit the following (in a single PDF) to LSO@vanderbilt.edu  by 5 p.m. on July 9: 

  1. Brief (2-page maximum) research plan including summary budget (overhead not allowed);
  2. Letter of support from department chair/center director;
    1. Letter must acknowledge that this grant does not allow indirect costs. This statement can be used/modified: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable institutional policy.”
  3. NIH Biosketch

Submissions should reference the program name in the subject line of the email.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


The 2020 TD Ready Challenge: Innovative COVID-19 Solutions

Applications due July 9

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Program Overview:

VUMC may submit 1 application to the TD Ready Challenge: Innovative COVID-19 Solutions. The Toronto-Dominion Bank (TD) Ready Challenge will fund grants of up to $1 million CAD [the present equivalent of $745,000 USD**] to provide innovative solutions that address the impacts of the COVID-19 pandemic, specifically for communities that are experiencing disproportionate impacts of COVID-19.

TD seeks applications that will help drive accelerated, sustained and equitable recovery. Applications must work to explicitly address inequities exacerbated by the pandemic, as well as one or more of the four interconnected drivers of change of the TD Ready Commitment (Financial SecurityVibrant PlanetConnected Communities and Better Health).

The pandemic is not only a health crisis, but also a social, economic and environmental one. In the face of COVID-19, these intrinsic links have never been clearer, and a holistic approach is needed to address the impacts. Today, COVID-19 and its devastating consequences have created a remarkable climate of uncertainty that has rippled through all aspects of our society. In the past few months alone, several studies have shown the significant impacts already being felt across North America, though not all people are experiencing these effects equally. There is growing evidence that COVID-19 is disproportionately impacting certain populations across North America including:

  • Individuals from racialized and/or newcomer communities;
  • Those who are a part of Indigenous communities;
  • Those that have unstable employment or inflexible working conditions;
  • Those experiencing insecure, inadequate, or nonexistent housing conditions;
  • Individuals living in remote communities and are socially or geographically isolated.

Competitive Projects Will:

  • Support communities experiencing disproportionate impacts of COVID-19 based on factors such as race, ethnicity, socioeconomic status and geographic location
  • Address impacts of COVID-19 by demonstrating promising approaches to helping build community resilience
  • Align with one or more of the drivers of change of the TD Ready Commitment (see above)
  • Have wide demographic or geographical reach in the areas TD operates within across North America
  • Use the grant to scale and/or replicate solutions to additional communities or populations (or pilot projects with material evidence of viable success and scalability)
  • Have a clear evaluation and measurement process to track impact
  • Enable new approaches that are innovative in nature

**Note that a maximum of 20% of the grant award can be directed towards overhead costs (i.e., office space and supplies, salaries, venue rentals, evaluation reporting, etc.)

See the program page and the common questions section for more information.

Internal Application Process:

Anyone interested in being considered as VUMC’s nominee must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on July 9.

  1. Brief research plan including summary budget (2 pages max, references may be included on a separate page)
  2. Letter of support from department chair/center director;
  3. NIH Biosketch

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu


NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional)

Applications due July 10

VUMC: These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Optional: Attend NIH Early Independence Award Q&A Webinar at 12pm on June 29. Pre-registration required.

Overview:

VUMC may submit two applications to the NIH Director's Early Independence Award. The award, part of the NIH High-Risk High-Reward Research program, supports exceptional investigators who wish to pursue independent research essentially after completion of their terminal doctoral/research degree or end of post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. 

Those wishing to apply for the NIH Director's Emergency Early Independence Award for SARS-CoV-2-related research must apply in response to the competition titled “NIH Director’s COVID-19 Emergency Early Independence Awards (DP5 Clinical Trial Optional)”

Though most newly graduated doctoral-level researchers would benefit from post-doctoral training, a small number of outstanding junior investigators are capable of launching directly into an independent research career. For those select junior investigators who already have established a record of scientific innovation and research productivity and who have demonstrated unusual scientific vision and maturity, typical post-doctoral training would unnecessarily delay their entry into independent research. The NIH Director’s Early Independence Award also provides an opportunity for institutions to invigorate their research programs by bringing in fresh scientific perspectives of the awardees they host.

By the end of the award period, the Early Independence Award investigator is expected to be competitive for continued funding of his/her research program through other NIH funding activities and for a permanent research-oriented position. See the program announcement for more information

Budget Info: Awards will be for up to $250,000 direct costs per year for 5 years.

Eligibility:

  • Applications are welcome in all biomedical research topics that have the potential ultimately to have a substantial impact on human health. In addition to the nominal biomedical sciences, these include, but are not limited to, relevant research topics in the behavioral, social, applied, and formal sciences. The potential for impact on human health may be near term (clinical or translational research) or long term (basic research).
  • Time window for eligibility: The receipt date of the terminal doctoral degree or end of post-graduate clinical training of the PD/PI must be between June 1, 2019 and September 30, 2021. The degree receipt date is that which appears on the official transcript for the degree. The end of post-graduate clinical training includes residency and fellowship periods.
  • At the time of application, the PD/PI must not have served as a post-doctoral fellow following a previous (not the most recent) doctoral degree for more than twelve months. To be consistent with the updated NIH definition of Early Stage Investigators, eligible clinical training includes clinical residency and clinical fellowship.
  • Research independence at time of application: Individuals are eligible only if they, at the time of application submission, do not have research independence. Eligible individuals must have all the following characteristics: The PD/PI's current research agenda is set through concurrence with mentors; the PD/PI's research is funded primarily through support to other investigators (mentored fellowships such as NIH F31 or F32 Fellowships or NSF Graduate Research Fellowships do not preclude eligibility); the PD/PI does not have any space assigned directly by the institution for the conduct of his/her research; the PD/PI, according to institutional policy, cannot apply for an NIH R01 grant without special waiver or exemption from the institution.
  • There is no U.S. citizenship requirement for PDs/PIs.

Level of effort: Individuals must commit at least 9.6 person-months each year (i.e., 80% effort of a 12-month appointment) to the Early Independence Award project in years 1-2 of the project period. In years 3-5, awardees may reduce effort towards the Early Independence Award project but must commit at least 9.6 person-months each year (i.e., 80% effort of a 12-month appointment) to independent research in general.

Internal Application Process:

Eligible faculty interested in being one of VUMC’s nominees must submit the following (in a single PDF) to LSO@vanderbilt.edu  by 5 p.m. on July 10: 

  1. Brief (2-page maximum) research plan including summary budget
  2. Letter of support from department chair/center director;
  3. NIH Biosketch

Submissions should reference “Director’s Award (General)” in the subject line of the email. Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


NIH Director’s COVID-19 Emergency Early Independence Awards (DP5 Clinical Trial Optional)

Applications due July 10

VUMC: These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Optional: Attend NIH Early Independence Award Q&A Webinar at 12pm on June 29. Pre-registration required.

Overview:

VUMC may submit two applications to the NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional) for SARS-CoV-2 / COVID-19 research. The award, part of the NIH High-Risk High-Reward Research program, supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce.

This FOA solicits applications responsive only to the COVID-19 public health emergency through support of the CARES Act. All other Early Independence Award applications must be submitted in response to the competition titled “NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional)”

Due to the COVID-19 public health emergency, funds provided by the CARES Act will support a total of 5-10 Early Independence Awards or Transformative Research Awards (separate RFA) that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics. As with all High-Risk, High-Reward Research program applications, innovation may be technological or conceptual.

Though most newly graduated doctoral-level researchers would benefit from post-doctoral training, a small number of outstanding junior investigators are capable of launching directly into an independent research career. For those select junior investigators who already have established a record of scientific innovation and research productivity and who have demonstrated unusual scientific vision and maturity, typical post-doctoral training would unnecessarily delay their entry into independent research. The NIH Director’s Early Independence Award also provides an opportunity for institutions to invigorate their research programs by bringing in fresh scientific perspectives of the awardees they host.

By the end of the award period, the Early Independence Award investigator is expected to be competitive for continued funding of his/her research program through other NIH funding activities and for a permanent research-oriented position.

Budget Info: Awards will be for up to $250,000 direct costs per year for 5 years.

Eligibility:

  • Research must be relevant to SARS-CoV-2/ COVID-19. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics.
  • Time window for eligibility: The receipt date of the terminal doctoral degree or end of post-graduate clinical training of the PD/PI must be between June 1, 2019 and September 30, 2021. The degree receipt date is that which appears on the official transcript for the degree. The end of post-graduate clinical training includes residency and fellowship periods.
  • At the time of application, the PD/PI must not have served as a post-doctoral fellow following a previous (not the most recent) doctoral degree for more than twelve months. To be consistent with the updated NIH definition of Early Stage Investigators, eligible clinical training includes clinical residency and clinical fellowship.
  • Research independence at time of application: Individuals are eligible only if they, at the time of application submission, do not have research independence. Eligible individuals must have all the following characteristics: The PD/PI's current research agenda is set through concurrence with mentors; the PD/PI's research is funded primarily through support to other investigators (mentored fellowships such as NIH F31 or F32 Fellowships or NSF Graduate Research Fellowships do not preclude eligibility); the PD/PI does not have any space assigned directly by the institution for the conduct of his/her research; the PD/PI, according to institutional policy, cannot apply for an NIH R01 grant without special waiver or exemption from the institution.
  • There is no U.S. citizenship requirement for PDs/PIs.

Level of effort: Individuals must commit at least 9.6 person-months each year (i.e., 80% effort of a 12-month appointment) to the Early Independence Award project in years 1-2 of the project period. In years 3-5, awardees may reduce effort towards the Early Independence Award project but must commit at least 9.6 person-months each year (i.e., 80% effort of a 12-month appointment) to independent research in general.

Internal Application Process:

Eligible faculty interested in being one of VUMC’s nominees must submit the following (in a single PDF) to LSO@vanderbilt.edu  by 5 p.m. on July 10: 

  1. Brief (2-page maximum) research plan including summary budget
  2. Letter of support from department chair/center director;
  3. NIH Biosketch

Submissions should reference “Director’s Award (COVID-19)” in the subject line of the email. Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


2021 Rita Allen Foundation Scholars Award

Applications due July 23

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Vanderbilt (VU and VUMC collaboratively) anticipates the opportunity to nominate one candidate for the Rita Allen Foundation Scholars Award Program. The foundation supports early-career biomedical scholars doing pioneering research. This award typically provides $550,000 over five years for young investigators involved in research in the cure and treatment of diseases in the fields of cancer, immunology, and neuroscience.

The foundation seeks candidates that show persuasive evidence of distinguished achievement or extraordinary promise in research in one of the relevant fields. The program embraces innovative research with above-average risk and groundbreaking possibilities. Rita Allen Foundation Scholars are distinguished by their bold approaches to basic scientific questions that address problems of global concern, as well as their potential for learning, leadership and collaboration.

Eligibility Criteria:

  • Candidates should be independent investigators in the early stages (preferably in the first 3 years) of a tenure track faculty appointment.
  • Candidates must have received committed startup funds and lab space from their respective institutions.
  • Scholars may not accept an award from the Beckman Young Investigator Program, Pew Scholars Program in the Biomedical Sciences, Searle Scholars Program or Vallee Scholars Program that would take effect beginning in year one of the RAF award.
  • The Foundation encourages a diverse pool of applicants that includes candidates from backgrounds that are underrepresented in the biomedical research field
  • The Foundation discourages repeat nominations of candidates not chosen in previous years.
  • U.S. citizenship is not a requirement

Visit the foundation’s website for full eligibility and application guidelines.

Internal Application Process:

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on July 23. Submissions should reference the program name in the subject line of the email.

  1. Brief research plan including summary budget; 2 pages max, references may be included on a separate page
    1. Budget guidelines: Up to 50% may be used for Scholar compensation. No indirect costs are allowed.
  2. Statement of support from department chair/center director;
    1. Letter must acknowledge that this grant does not allow indirect costs.** This statement can be used/modified: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable institutional policy.”
  3. NIH Biosketch or Brief CV (5 page max)

Once received, all proposals will be forwarded to an internal review committee that will choose the final nominee. The chosen nominee will submit a letter of inquiry to the Foundation by the September 9, 2020 deadline, and a full application is due on October 21, 2020.

**Process for cost-sharing typically coordinated at the departmental level and approved by department chair and/or dean. Please consult LSO@vanderbilt.edu for further guidance.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


Research Awards Banner.png

Active Calls for NON-Limited External Opportunities 

Internal review process NOT required- Submit directly to Sponsor

The VUMC Corporate & Foundation Relations team provides hands-on proposal development assistance for non-federal awards. Contact cfr@vumc.org for more information.


Damon Runyon-Rachleff Innovation Award

Applications due July 1

Interested applicants are strongly encouraged to contact Adele White, Director of Corporate & Foundation Relations (adele.white@vumc.org) for more information about this opportunity.

The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. Awards are made to institutions for support of the Damon Runyon-Rachleff Innovation Investigators. 

Applications will be evaluated based on the following: 

  • The applicant’s capacity to conduct bold, exceptionally creative research.
  • The novelty and creativity of the proposed research. Incremental research will not be funded.
  • The potential of the proposed research to lead to advances that will significantly impact the prevention, diagnosis, treatment or basic understanding of cancer.
  • The applicant’s lack of resources to pursue the proposed research.

Eligibility (see additional requirements on program website)

  • The applicant must have received an MD, DO, PhD, or MD/PhD degree(s) from an accredited institution.
  • Basic and translational/clinical projects will be considered.  Applications will be accepted from all scientific disciplines provided that the proposed research meets the selection criteria.
  • Applicants with a background in multiple disciplines are especially encouraged to apply.
  • Joint submission from two collaborators working in different disciplines will be considered. (The collaborators will share the award.) Each collaborator must meet the eligibility criteria.
  • Applicants must belong to one of the following categories:
    • Tenure-track Assistant Professors within the first five (5) years of obtaining their initial Assistant Professor position (Cut-off date: July 1, 2015).
    • Clinical Instructors and Senior Clinical Fellows (in the final year of their sub-specialty training) holding an MD, MD/PhD, DO who are pursuing a period of independent research before taking a tenure-track faculty position.  Such individuals must have an exceptional record of research accomplishment, dedicated laboratory space and the support of their institution.
    • Distinguished Fellows with an exceptional record of research accomplishment identified by their institution to pursue an independent research program and who have dedicated laboratory space.  These candidates are markedly distinct from traditional postdoctoral fellows.  Examples: Whitehead Fellows, UCSF Fellows, Cold Spring Harbor Fellows.
      [Research Assistant Professors, Research Associate Professors, Research Scientists and Postdoctoral Fellows are not eligible.  If you are unsure about your eligibility for this award program, please contact the Foundation's Award Programs at 212.455.0520.]
  • Applicants are expected to commit a minimum of 80% of their time to conducting research.

DoD Peer Reviewed Cancer Research Program – Multiple Award Types

Letters of intent due July 30

Details for all award types found at: https://cdmrp.army.mil/funding/prcrp 
 
Virtual Cancer Center – Director Award and the Career Development Award – Scholar Option 
Together these funding opportunities offer a unique opportunities for leadership and mentorship. The Virtual Cancer Center Director Award (VCCDA) mechanism is a unique, interactive virtual cancer center (VCC) focused on bringing together two established investigators (Director and Deputy Director) and up to nine early career investigators (Scholars) to interrogate the commonalities of cancer. As the leadership of the VCC, the Director and Deputy Director will have the ability to shape the vision VCC and how it will succeed in its mission to train the next generation of cancer researchers. Please see more information: https://cdmrp.army.mil/prcrp/research_highlights/20VCCDA_highlight 
 
Career Development Award – Fellow Option
This funding opportunity supports independent, early-career investigators (referred to as Fellows) to conduct impactful research with the guidance of an experienced cancer researcher (i.e., Career Guide).  Presents an opportunity for Fellows to obtain the funding, guidance, and experience necessary for productive, independent careers at the forefront of cancer research.
 
Behavioral Health Science Award
The overall goal of the is Behavioral Health Science Award to advance behavioral health cancer science and fill gaps in the understanding of survivorship, including investigations into the psychological health and well-being of those affected by cancer (e.g., patients, family members). Studies proposed may span behavioral health research that examines quality of life, decision making and/or cognitive function, development and testing of educational interventions, and symptom management (e.g., toxicity of treatment, palliative care, psychological distress and anxiety).
 
Translational Team Science Award
The Translational Team Science Award is intended to support advanced translational studies that are based on results from clinical investigations (i.e. clinical trials). Research projects should address critical knowledge gaps in clinical outcomes, validate key research results, expand upon potentially game-changing results, or investigate novel clinical findings.

To Apply:
 
Submission is a two-step process requiring both pre-application submission and full application submission.

Detailed descriptions of funding opportunities, evaluation criteria, and submission requirements can be found in the specific Program Announcements. The Program Announcements are available electronically for downloading from the Grants.gov website (http://www.grants.gov), the CDMRP website (https://cdmrp.army.mil/funding/prgdefault) and the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org). Submission is a two-step process requiring both pre-application submission and full application submission.


Burroughs Wellcome Fund- Investigators in the Pathogenesis of Infectious Disease

Pre-proposals due July 31

Interested applicants are strongly encouraged to contact Sue Reeves, Executive Director of Foundation Relations (sue.reeves@vumc.org) for more information about this opportunity.

About the Award

The Investigators in the Pathogenesis of Infectious Disease (PATH) award provides $500,000 over five years to support accomplished investigators at the assistant professor level to study pathogenesis, with a focus on the interplay between human and microbial biology, shedding light on how human and microbial systems are affected by their encounters. 

Details

The Investigators in the Pathogenesis of Infectious Disease program provides opportunities for assistant professors to bring multidisciplinary approaches to the study of human infectious diseases. The goal of the program is to provide opportunities for accomplished investigators still early in their careers to study what happens at the points where the systems of humans and potentially infectious agents connect. The program supports research that sheds light on the fundamentals that affect the outcomes of these encounters: how colonization, infection, commensalism, and other relationships play out at levels ranging from molecular interactions to systemic ones.

From this year forward, microbiome-related proposals must be infectious disease focused to compete well in this program.

PATH is a highly competitive award program that provides $500,000 over a period of five years. The awards are intended to give recipients the freedom and flexibility to pursue new avenues of inquiry, stimulating higher risk research projects that hold potential for significantly advancing understanding of how infectious diseases work and how health is maintained.

How to Apply

Visit https://www.bwfund.org/grant-programs/infectious-diseases/investigators-in-pathogenesis-of-infectious-disease

The competition will employ a two-stage process.  After review of pre-proposals, full proposal invitations will be sent by October 2, 2020. 

All applicants will be required to complete a web-based questionnaire assessing their eligibility to apply for this program.  If eligibility are met, applicants will automatically directed to the web-based pre-proposal application.